Profile
ACER NVO VRTX REGN MRNA SGEN
Company Name Acer Therapeutics Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $16.15M $563.06B $109.10B $105.53B $44.96B $43.15B
Employees 0.03K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Christopher Schelling Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
Trading
ACER NVO VRTX REGN MRNA SGEN
Last Close $0.6601 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $1.28 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $0.57 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -48.43 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 15.81 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ACER NVO VRTX REGN MRNA SGEN
1 Month Return 0 % 2.41 % 5.63 % 5.81 % 9.63 % 0 %
3 Month Return 0 % 5.96 % -0.03 % 2.14 % 34.21 % 0 %
6 Month Return -23.91 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return -8.36 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return 0 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return -12.65 % -24.01 % 20.66 % 30.61 % -8.64 % 14.66 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACER NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -280.47 % 1.1 % 13.85 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ACER NVO VRTX REGN MRNA SGEN
Asset Growth -67.94 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -100 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth -100 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year 100 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -54.34 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -89.16 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 38.25 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 54.01 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share 98.44 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -54.34 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -22323.93 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 34.38 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 49.71 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG 98.3 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -71.84 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -71.84 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -780.01 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -158.4 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -117.58 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -102.91 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 2912.5 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -15924.54 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ACER NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 77.46 % 84.65 % 86.91 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -435.08 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM 196.73 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM 35.69 % 82.5 % 21.07 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 125.64 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 285 % 101.7 % 112.45 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -4575.9 % 45.03 % 41.62 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -213.83 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.01 2.88 0.42 2.51 22.04 2.52
Inventory Turnover TTM 0.02 1.12 1.64 0.62 13.67 1.07
Fixed Asset Turnover TTM 907.34 % 248.64 % 685.54 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 2.66 % 81.71 % 42.58 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -1.59 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -1.59 11.28 14.17 36.87 -9.61 -3.73
Cash Per Share TTM 2.43 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -10440.17 % 38.24 % 38.72 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.36 % 53.85 % 92.78 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -213.83 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -0.41 77.52 29.81 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -0.42 42.47 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -0.42 42.47 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ACER NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.02B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.03B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -1.77 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ACER NVO VRTX REGN MRNA SGEN
Long Term Debt $0.01B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $-0.02B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.01B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.01B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ACER NVO VRTX REGN MRNA SGEN
Net Income $-0.03B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABSI Absci Corporation 4.91
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ACER
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 258.05
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 114.52
IWC iShares Micro-Cap ETF 0.0034 117.111
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.03 33.28
Unlock